{ "model": { "rank": 6058, "code": "thing-q185137", "model_id": "vr.tr.thalassemia", "name": "thalassemia", "purpose": "Let an agent explain thalassaemia and its types in general terms, relay screening, carrier testing and management information from health authorities and patient organisations, and route personal diagnosis, results and treatment questions to clinicians.", "family": "Thing Registry", "category": "Cross-cutting context", "status": "research-draft", "kind": "thing", "plane": "XCT", "domain": "XCT.STA", "industry": "", "version": "", "url": "/models/thing/q185137/", "tier": 2, "score": 63, "payload": { "layer": "wikidata", "aliases": [ "Sickle cell-beta thalassemia", "idiopathic hydrops fetalis", "Hemoglobin Barts", "alpha thalassemia", "beta thalassemia", "hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome", "Alpha thalassemia abnormal morphogenesis", "hemoglobin H disease", "ATR-16 syndrome", "thalassemia minor", "delta thalassemia", "dominant beta-thalassemia", "beta-thalassemia major", "beta-thalassemia intermedia" ], "aliasCount": 14, "merged": 14, "knownIn": 63, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q185137", "url": "https://www.wikidata.org/wiki/Q185137", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-12T20:06:18Z", "providers": [ "Claude" ], "breadth": "written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify", "pass": 2, "wave": 3, "engine": "claude" }, "metaModel": { "id": "THING-Q185137", "registryId": "vr.tr.thalassemia", "name": "thalassemia", "version": "0.2.0-wave.3", "entryKind": "thing", "family": "Thing Registry", "domain": [ "XCT.STA" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q185137/", "model": { "registry_id": "vr.tr.thalassemia", "name": "thalassemia", "purpose": "Let an agent explain thalassaemia and its types in general terms, relay screening, carrier testing and management information from health authorities and patient organisations, and route personal diagnosis, results and treatment questions to clinicians.", "definition": "A group of inherited blood disorders in which the body makes less of one of the globin chains of haemoglobin, alpha or beta, causing anaemia that ranges from no symptoms in carriers to severe transfusion-dependent disease; common in populations from the Mediterranean, Middle East, South and Southeast Asia and Africa, and managed by transfusion, iron chelation, and in some cases stem cell transplantation or gene therapy.", "what_it_is_for": "Not applicable; a disorder.", "affordances": [ "explain types and inheritance in general terms", "relay screening and carrier testing information", "relay management options from guidelines", "route personal questions to clinicians" ], "distinguishing_features": [ "Reduced globin chain synthesis", "Alpha and beta forms with graded severity", "Autosomal recessive inheritance", "Regional prevalence linked to malaria history" ], "appearance": "Not visible as an object; anaemia, fatigue and, in severe forms, growth and bone changes.", "visual_identification": [ "Inherited reduction of alpha or beta globin", "Carrier state versus intermediate and major disease", "Sickle cell disease and iron deficiency anaemia are different conditions" ], "physical_properties": [ { "quantity": "carriers worldwide", "typical_range": "hundreds of millions", "unit": "people", "note": "WHO estimates" }, { "quantity": "inheritance", "typical_range": "autosomal recessive", "unit": "pattern", "note": "" } ], "families_and_kinds": [ "alpha thalassaemia including haemoglobin H disease and haemoglobin Bart hydrops", "beta thalassaemia minor, intermedia and major", "combined sickle cell beta thalassaemia", "thalassaemia carrier states" ], "related_models": [ { "relation": "is a kind of", "target": "haemoglobinopathy", "why": "a disorder of haemoglobin" }, { "relation": "is a kind of", "target": "autosomal recessive disease", "why": "inheritance pattern" }, { "relation": "is confused with", "target": "iron deficiency anaemia", "why": "a common misdiagnosis" }, { "relation": "is related to", "target": "sickle cell disease", "why": "another haemoglobin disorder" } ], "identifiers": [ { "scheme": "ICD-10", "value_or_pattern": "D56", "note": "" }, { "scheme": "ICD-11", "value_or_pattern": "3A50", "note": "" }, { "scheme": "OMIM", "value_or_pattern": "613985 and others", "note": "genetic entries" } ], "standards_and_regulation": [ "National screening programmes for carriers and newborns", "Clinical guidelines from thalassaemia and haematology bodies", "Blood transfusion safety standards", "Rare disease frameworks" ], "failure_modes_and_hazards": [ "Iron overload from transfusion without chelation", "Missed carrier status before pregnancy", "Misdiagnosis as iron deficiency", "Agents giving personal medical advice" ], "in_scope": [], "out_of_scope": [], "characteristics": [] }, "sources": [], "structure": { "bundles": [ { "id": "understand", "name": "Understand", "description": "What thalassaemia is.", "rationale": "General information.", "layers": [ { "id": "genetics", "name": "Genetics", "description": "Cause and inheritance.", "findings": [ { "id": "genetics-finding", "name": "Genetics", "description": "Genetics.", "questions": [ { "text": "What causes thalassaemia, and how is it inherited?", "kind": "definition" }, { "text": "Is the user asking about their own or their family results, which needs a clinician or genetic counsellor?", "kind": "boundary" } ] } ] }, { "id": "types", "name": "Types", "description": "Types and severity.", "findings": [ { "id": "types-finding", "name": "Types", "description": "Types.", "questions": [ { "text": "How do alpha and beta forms and carrier, intermediate and major states differ?", "kind": "definition" }, { "text": "Which entry fits sickle cell disease?", "kind": "action" } ] } ] } ] }, { "id": "screen", "name": "Screen", "description": "Screening and diagnosis.", "rationale": "Screening.", "layers": [ { "id": "screening", "name": "Screening", "description": "Screening programmes.", "findings": [ { "id": "screening-finding", "name": "Screening", "description": "Screening.", "questions": [ { "text": "What screening and carrier testing programmes exist, and who is offered them?", "kind": "provenance" }, { "text": "Which programme applies in the country in question?", "kind": "boundary" } ] } ] }, { "id": "diagnosis", "name": "Diagnosis", "description": "Diagnosis.", "findings": [ { "id": "diagnosis-finding", "name": "Diagnosis", "description": "Diagnosis.", "questions": [ { "text": "How is thalassaemia diagnosed, in general terms?", "kind": "provenance" }, { "text": "Which entry fits haematology tests?", "kind": "action" } ] } ] } ] }, { "id": "manage", "name": "Manage", "description": "Treatment and living.", "rationale": "Care.", "layers": [ { "id": "treatment", "name": "Treatment", "description": "Treatment.", "findings": [ { "id": "treatment-finding", "name": "Treatment", "description": "Treatment.", "questions": [ { "text": "What treatments do guidelines describe, from transfusion and chelation to transplantation and gene therapy?", "kind": "provenance" }, { "text": "Is the presentation free of personal treatment advice?", "kind": "boundary" } ] } ] }, { "id": "living", "name": "Living", "description": "Living with thalassaemia.", "findings": [ { "id": "living-finding", "name": "Living", "description": "Living.", "questions": [ { "text": "What support and patient organisations exist?", "kind": "provenance" }, { "text": "Which entry fits patient support?", "kind": "action" } ] } ] } ] }, { "id": "public", "name": "Public health", "description": "Epidemiology and research.", "rationale": "Population.", "layers": [ { "id": "epidemiology", "name": "Epidemiology", "description": "Distribution.", "findings": [ { "id": "epidemiology-finding", "name": "Epidemiology", "description": "Epidemiology.", "questions": [ { "text": "Where is thalassaemia common, and why, with figures from WHO?", "kind": "measurement" }, { "text": "Which sources are cited?", "kind": "provenance" } ] } ] }, { "id": "research", "name": "Research", "description": "Research.", "findings": [ { "id": "research-finding", "name": "Research", "description": "Research.", "questions": [ { "text": "What research and new therapies are under way, with attribution?", "kind": "provenance" }, { "text": "Which references are standard?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Should alpha and beta forms be separate entries?", "How should screening programmes be linked by country?", "The registry entry has merged aliases for specific syndromes; should they be split off?" ], "statistics": { "bundles": 4, "layers": 8, "findings": 8, "questions": 16 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "abstract concept", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a thalassemia, record what state it is in, and decide what may be done with it.", "whatItIs": "Let an agent explain thalassaemia and its types in general terms, relay screening, carrier testing and management information from health authorities and patient organisations, and route personal diagnosis, results and treatment questions to clinicians.", "characteristics": { "substance": "abstract", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: Sickle cell-beta thalassemia, idiopathic hydrops fetalis, Hemoglobin Barts, alpha thalassemia, beta thalassemia, hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome, Alpha thalassemia abnormal morphogenesis, hemoglobin H disease, ATR-16 syndrome, thalassemia minor, delta thalassemia, dominant beta-thalassemia.", "14 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 63 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a thalassemia, and on what evidence are they told apart?" ], "whatItIsMadeOf": "an abstraction with no physical instance", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about." ], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "Sickle cell-beta thalassemia", "idiopathic hydrops fetalis", "Hemoglobin Barts", "alpha thalassemia", "beta thalassemia", "hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome", "Alpha thalassemia abnormal morphogenesis", "hemoglobin H disease", "ATR-16 syndrome", "thalassemia minor", "delta thalassemia", "dominant beta-thalassemia" ] } ], "standing": "Described in 63 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 14 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one thalassemia from another, and a thalassemia from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a thalassemia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a thalassemia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a thalassemia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a thalassemia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a thalassemia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a thalassemia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a thalassemia sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a thalassemia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a thalassemia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a thalassemia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a thalassemia from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a thalassemia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a thalassemia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a thalassemia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a thalassemia passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a thalassemia between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a thalassemia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a thalassemia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a thalassemia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a thalassemia, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a thalassemia is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a thalassemia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a thalassemia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a thalassemia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "definitions-in-contest", "name": "Definitions and who holds them", "description": "What thalassemia is taken to mean, and by whom.", "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.", "layers": [ { "id": "competing-definitions", "name": "Competing definitions", "description": "The main readings and the traditions behind them.", "findings": [ { "id": "definition-map", "name": "Definitions and their holders", "description": "Each definition with the school or body that holds it.", "questions": [ { "id": "definition-map-q01", "text": "Which definitions of thalassemia are in use, and which tradition or body holds each?", "kind": "definition" }, { "id": "definition-map-q02", "text": "What turns on the difference between them in practice?", "kind": "boundary" } ] } ] }, { "id": "operationalisation", "name": "Operationalisation", "description": "How it is measured or applied when it has to be.", "findings": [ { "id": "operational-record", "name": "Measures and proxies", "description": "Instruments and indicators used to stand in for it.", "questions": [ { "id": "operational-record-q01", "text": "How is thalassemia operationalised or measured in practice, and by what instrument?", "kind": "measurement" }, { "id": "operational-record-q02", "text": "What does that operationalisation leave out, and when does that matter?", "kind": "boundary" } ] } ] } ] }, { "id": "instances-and-use", "name": "Instances, use and consequence", "description": "What counts as an instance of thalassemia and what follows from calling something that.", "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.", "layers": [ { "id": "instances", "name": "What counts as an instance", "description": "Clear cases, borderline cases and non-cases.", "findings": [ { "id": "instance-tests", "name": "Tests for an instance", "description": "What would settle whether something falls under it.", "questions": [ { "id": "instance-tests-q01", "text": "What would settle whether something is an instance of thalassemia?", "kind": "boundary" }, { "id": "instance-tests-q02", "text": "Which borderline cases are argued about, and on what grounds?", "kind": "definition" } ] } ] }, { "id": "consequence", "name": "Consequence of application", "description": "Rights, duties or decisions that follow from the label.", "findings": [ { "id": "consequence-record", "name": "What the label licenses", "description": "What an agent may do once something is classified this way.", "questions": [ { "id": "consequence-record-q01", "text": "What follows practically once something is treated as thalassemia?", "kind": "action" }, { "id": "consequence-record-q02", "text": "What must an agent not infer from the label alone?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a thalassemia came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a thalassemia and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a thalassemia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a thalassemia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a thalassemia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a thalassemia is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a thalassemia, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a thalassemia, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a thalassemia is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 5, "layers": 10, "findings": 12, "questions": 32 } } } }